Global Nuclear Imaging Devices Market, By Product (Single Photon-Emission Computed Tomography (SPECT), Hybrid Pet, Planar Scintigraphy), Application (Oncology, Cardiology, Neurology, Others), End User (Hospitals, Imaging Centers, Academic and Research Centers, Others) - Industry Trends and Forecast to 2031.
Nuclear Imaging Devices Market Analysis and Size
Over the last few years, the market recovery has been led by the increasing prevalence of chronic diseases. Patients' hospital visits for imaging diagnosis surged, so the industry saw a huge surge in diagnostics and treatment. Also, the Nuclear Regulatory Commission (NRC) of the U.S. supervises nuclear imaging equipment manufacture and use, along with radiation therapy and research. It has agreements with 37 states in the U.S. that enable them to govern the wide use of certain radioactive materials by issuing licenses to clinics, hospitals, and medical facilities.
Data Bridge Market Research analyses that the global nuclear imaging devices market which was USD 3.07 billion in 2023, will reach upto 4.86 billion by 2031, and is expected to undergo a CAGR of 5.9% during the forecast period. “Hospitals” dominates the End User segment of the Nuclear Imaging Devices market due to increasing awareness for proper diagnostics. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Nuclear Imaging Devices Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2031
|
|
Base Year
|
2023
|
|
Historic Years
|
2022 (Customizable to 2016-2021)
|
|
Quantitative Units
|
Revenue in USD Billion, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Product (Single Photon-Emission Computed Tomography (SPECT), Hybrid Pet, Planar Scintigraphy), Application (Oncology, Cardiology, Neurology, Others), End User (Hospitals, Imaging Centers, Academic and Research Centers, Others)
|
|
Countries Covered
|
U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa, Brazil, Argentina, and Rest of South America
|
|
Market Players Covered
|
DIGIRAD CORPORATION (U.S.), Neusoft Corporation (China), CANON MEDICAL SYSTEMS CORPORATION (Japan), SurgicEye GmbH (Germany), CMR Naviscan. (U.S.), Absolute Imaging Inc. (Canada), Bartec Technologies Ltd. (U.K.), BCL X-Ray Canada Inc. (Canada), TTG Imaging Solutions, LLC (U.S.), Ashby Gorman Baker Ltd. (Belgium), Lucerno Dynamics, LLC. (U.S.), Berthold Technologies GmbH & Co.KG (Germany), Incom, Inc. (U.S.), Siemens (U.S.), Koninklijke Philips N.V. (Netherlands), and Spectrum Dynamics Medical (Switzerland)
|
|
Market Opportunities
|
|
Market Definition
Nuclear imaging devices are the pieces of medical imaging equipment widely used in radioactive materials to evaluate the severity of conditions such as cancer, endocrine, gastrointestinal, cardiovascular, neurological, and other brain issues. These non-invasive technologies offer clinicians operational data at the molecular and cellular levels, enabling them to diagnose and evaluate medical problems. The primary product types in nuclear imaging devices and equipment are PET systems, SPECT systems, and planar scintigraphy.
Nuclear Imaging Devices Market Dynamics
Drivers
- Increasing Prevalence of Breast Cancer
There has been an increasing incidence of breast cancer, leading to increased market growth. As per the Breast Cancer Factsheet Now 2021, about 55,000 women and 370 men in the U.K. are diagnosed with breast cancer each year. Breast cancer has led to the death of an estimated 600,000 people in the U.K. This increasing incidence leads to the higher adoption of nuclear imaging devices that help properly detect the devices. Thus, this factor boosts market growth.
- Increasing Technological Advancements
The technological advancements in the market led to market growth. Those multimodality imaging systems include SPECT/CT, PET/CT, PET/MRI, and PET/SPECT/CT. For instance, Spectrum Dynamics announced its latest development in digital nuclear medicine imaging capability to image high-energy isotopes using solid-state detector technology in a 3600-CZT-based, wide-bore SPECT/CT configuration in 2022. This is expected to impact the market growth positively.
Opportunities
- Growing Prevalence of Chronic Diseases
The increasing incidence of heart disease is anticipated to boost the market's growth. According to the American Heart Association 2021 Journal, it is projected that by 2035, more than 130 million adults in the U.S. will have some heart disease. Thus, the increasing incidence of chronic diseases such as cancer and cardiac diseases is anticipated to surge the demand for early and effective diagnosis, thus enhancing the growth of the nuclear imaging market over the forecast period. Therefore, this factor boosts the market growth.
- Increasing Rate of Strategic Initiatives by Market Players
The major market players are working on strategic initiatives such as acquisitions, mergers, partnerships, and product launches to increase the market growth. For instance, Koninklijke Philips NV and Rennes University Hospital signed a five-year innovation and technology partnership to support PET diagnostics, interventional imaging, patient monitoring, and management, among other things in 2021. Thus, this factor boosts the market's growing rapidly.
Restraints/Challenges
- Strict Regulations for Nuclear Imaging Devices
The nuclear imaging devices and equipment market is limited by strict regulations by the Nuclear Regulatory Commission (NRC) medical use. For instance, the NRC needs nuclear imaging equipment licensees to use and store radioactive materials to safeguard workers and people by eradicating unwanted exposure, leading to relatively few nuclear imaging equipments being manufactured. Thus, these factors hamper the market growth.
This nuclear imaging devices market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the nuclear imaging devices market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Nuclear Imaging Devices Market Scope
The nuclear imaging devices market is segmented on the basis of product, application, and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product
- Single Photon-Emission Computed Tomography (SPECT)
- Hybrid SPECT Systems
- Standalone SPECT Systems
- Hybrid Pet
- Planar Scintigraphy
Application
- Oncology
- Cardiology
- Neurology
- Others
- Urology
- Orthopedics
- Gastroenterology
- Thyroid-Related Disorders
End User
- Hospitals
- Imaging Centers
- Academic and Research Centers
- Others
Nuclear Imaging Devices Market Regional Analysis/Insights
The nuclear imaging devices market is analyzed and market size insights and trends are provided by product, application, and end user as referenced above.
The countries covered in the nuclear imaging devices market report are U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, rest of Asia-Pacific, Saudi Arabia, U.A.E., South Africa, Egypt, Israel, rest of Middle East and Africa, Brazil, Argentina, and rest of South America.
North America is expected to dominate the nuclear imaging devices market due to availability of major market players. The increase in the prevalence of cancer and cardiovascular will further enhance the growth of the nuclear imaging devices market in the region during the forecast period.
Asia-Pacific is the fastest-growing region due to the rise in public and private investments for the improvements of medical infrastructure. Furthermore, the increase in the elderly population is further estimated to boost the growth of the nuclear imaging devices market in the region in the upcoming years.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The global nuclear imaging devices market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for nuclear imaging devices market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on nuclear imaging devices market. The data is available for historic period 2010-2020.
Competitive Landscape and Nuclear Imaging Devices Market Share Analysis
The nuclear imaging devices market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to nuclear imaging devices market.
Some of the major players operating in the nuclear imaging devices market are:
- DIGIRAD CORPORATION (U.S.)
- Neusoft Corporation (China)
- CANON MEDICAL SYSTEMS CORPORATION (Japan)
- SurgicEye GmbH (Germany)
- CMR Naviscan. (U.S.)
- Absolute Imaging Inc. (Canada)
- Bartec Technologies Ltd. (U.K.)
- BCL X-Ray Canada Inc. (Canada)
- TTG Imaging Solutions, LLC (U.S.)
- Ashby Gorman Baker Ltd. (Belgium)
- Lucerno Dynamics, LLC. (U.S.)
- Berthold Technologies GmbH & Co.KG (Germany)
- Incom, Inc. (U.S.), Siemens (U.S.)
- Koninklijke Philips N.V. (Netherlands)
- Spectrum Dynamics Medical (Switzerland)
SKU-